Skip to main content

Advertisement

SpringerLink
Log in

Some chemical and biochemical aspects of the problem of atherosclerosis

  • THE SEARCH FOR NEW DRUGS
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This review summarizes the most important data relating to the chemical and biological aspects of the problem of atherosclerosis – one of the most severe cardiovascular diseases, which currently leads to significant numbers of lethal outcomes. The causes of this chronic disease and its main therapeutic and biochemical parameters are discussed. Methods for the treatment of atherosclerosis are considered, along with an assessment of the drugs used, including the most convenient syntheses of these drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. V. G. Granik, The Metabolism of Exogenous Compounds [in Russian], Vuzovskaya Kniga, Moscow (2006).

    Google Scholar 

  2. A. Sevanian, L. Asatryan, and O. Ziouzenkova, Blood Purif., 17, 66 – 78 (1999).

    Article  PubMed  CAS  Google Scholar 

  3. O. Ziouzenkova and A. Sevanian, Blood Purif., 18, 169 – 176 (2000).

    Article  PubMed  CAS  Google Scholar 

  4. D. Bonnefont-Rousselot, P. Therond J.-L. Beaudeux, et al., Clin. Chem. Lab. Med., 37(10), 939 – 947 (1999).

    Article  PubMed  CAS  Google Scholar 

  5. G. K. Hansson, Atheroscler. Thromb. Vasc. Biol., 21(12), 1876 – 1890 (2001).

    Article  CAS  Google Scholar 

  6. J. Frosegard, A. K. Ulfgren, P. Nyberg, et al., Atheroscler., 145(1), 33 – 43 (1999).

    Article  Google Scholar 

  7. A. N. Orekhov, V. V. Tertov, and E. V. Pivovarova, Cardiology, 89, 111 – 118 (1998).

    Article  PubMed  CAS  Google Scholar 

  8. F. Bossert, Wipperfal-Elberfeld, and W. Vater, US 3485847 (1967).

  9. F. Dengel, US 6261359 (1966).

  10. A. F. Crowther and F. H. Smith, US 3337628 (1962).

  11. S. Zadelaar, R. Kleeman, L. Verscheuren, et al., Atheroscler. Thromb. Vasc. Biol., 27, 1706 – 1721 (2007).

    Article  CAS  Google Scholar 

  12. T. Rosen and C. H. Heathcock, Tetrahedron, 42(18), 4909 – 4912 (1986).

    Article  CAS  Google Scholar 

  13. R. N. Moore, G. Bigam, J. K. Chan, et al., J. Amer. Chem. Soc., 107(12), 2694 (1985).

    Article  Google Scholar 

  14. G. H. Tech, Clin. Exp. Pharmacol. Physiol., 43, 1016 – 1020 (2007).

    Google Scholar 

  15. J. A. Cella, L. Forest, and R. Tweit, US 3013012 (1961).

  16. R. S. Rosenson, Atheroscler., 171, 87 – 96 (2003).

    Article  CAS  Google Scholar 

  17. L. A. Carlson, Curr. Opin. Cardiol., 21, 336 – 344 (2006).

    PubMed  Google Scholar 

  18. P. Holvoet and D. Collen, Atherosclerosis, 137, Supplement 1, 33 – 38 (1998).

    Article  Google Scholar 

  19. K. Nakajima, T. Nakano, and A. Tanaka, Clin. Chem. Acta, 367, 36 – 47 (2006).

    Article  CAS  Google Scholar 

  20. S. Dudley-Brown, J. Cardiovasc. Nurs., 19(6), 421 – 427 (2004).

    PubMed  Google Scholar 

  21. D. Odzhius, T. Darwill, and P. Bavali, V Mire Nauki, No. 8, 55 – 61 (2005).

  22. E. Chazov, Atherosclerosis: Facts, Hypotheses, Speculations. In Search of Truth, http:nedug/Russia/lit/terap/oioct/tgherap35/therap.hmt.

  23. M. D. Mashkovskii, Medicine. Textbook for Doctors [in Russian], Torgsin, Khar’kov (1997), Vol. 1, 2.

    Google Scholar 

  24. W. G. M. Jones, J. M. Meyrick, and W. S. Waring, US 3262850 (1958).

  25. M. B. Neuworth and P. Pa, US 3576883 (1971).

  26. I. F. Charo and M. B. Taubman, Circ. Res., 95, 858 – 861 (2004).

    Article  PubMed  CAS  Google Scholar 

  27. C. Buccellaty, A. Sala, G. Rossoni, et al., J. Pharmacol. Exp. Ther., 317, 830 – 837 (2006).

    Article  Google Scholar 

  28. D. Aubert, P. Du Touch, R. S. Saint-Agne, et al., US 4529596 (1985).

  29. C. Casagrande, US Patent 6,625,078 B1 (2003).

  30. C. Napoli and L. J. Ignarro, Nitric Oxide: Biol. and Chem., 5(2), 88 – 97 (2001).

    Article  CAS  Google Scholar 

  31. V. G. Granik and N. B. Grigor’ev, Nitric Oxide [in Russian], Vuzovskaya Kniga, Moscow (2004).

    Google Scholar 

  32. C. R. White, R. P. Patel, and V. D. Darley-Usmar, Methods in Enzymology, L. Parker (ed.), Academic Press, San Diego, Boston, New York, Sydney, Tokyo, Toronto (1999), Vol. 301, Part C, pp. 288 – 301.

  33. T. Yamamoto and R. J. Bing, Proc. Soc. Exp. Biol. Med., 223(3), 200 – 209 (2000).

    Article  Google Scholar 

  34. J. P. Eiserich, M. Hristova, C. E. Cross, et al., Nature, 391, 393 – 397 (1998).

    Article  PubMed  CAS  Google Scholar 

  35. J. R. Prous (ed.), Annual Drug Data Rep., 19(11), 911 (1997).

Download references

Author information

Authors and Affiliations

  1. Moscow Scientific-Applied Narcology Center, Moscow, Russia

    V. G. Granik

Authors
  1. V. G. Granik
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

*Deceased (V. G. Granik).

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 46, No. 3, pp. 9 – 24, March, 2012.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Granik, V.G. Some chemical and biochemical aspects of the problem of atherosclerosis. Pharm Chem J 46, 139–153 (2012). https://doi.org/10.1007/s11094-012-0749-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-012-0749-5

Key words

Search

Navigation